Fibrotic disorders are complex diseases believed to stem from uncontrolled and excessive wound healing processes. The exact causes of these disorders are difficult to determine due to the intricate regulation of inflammation involved. Understanding these mechanisms is crucial as organ fibrosis, a life-threatening condition, can currently only be treated with transplants.
This note gathers publications that exemplify various applications of HTRF™ and AlphaLISA™ assays to advance fibrosis related research and shows how other researchers have harnessed these technologies to move their studies forward.
For research use only. Not for use in diagnostic procedures.
HTRF and AlphaLISA assays bring clarity to extracellular matrix related fibrosis development